五月天堂婷婷爱,色狠狠天天综合色香阁,91免费看国产,久久久久成人精品亚洲国产av综合,91啦在线播放,免费a一级毛片在线播放,天天日日夜夜看综合网,亚洲成人国产精品,奇米影视7777狠狠狠狠色,日韩精品高清在线观看,福利久久久,久久99国产精品片久久99蜜桃,91香蕉视频网址,婷婷91,久久久久久臀欲欧美日韩,少妇丰满大乳被男人揉捏视频

The expected timeframe for obtaining FDA registration and certification in the United States varies depending on the product type and regulatory pathway:

1. Medical Devices:

   • 510(k) Notification: Typically takes about 90 days for review. Including preparation and potential follow-ups, the entire process may take 3 to 6 months.
   • Premarket Approval (PMA): Generally ranges from 180 to 360 days. With preparation and possible additional information requests, the process may extend up to a year or more.
   • De Novo Classification: Usually about 120 days for review. Total time may be longer depending on the complexity of the device.

2. Drugs:

   • New Drug Application (NDA): Standard review takes around 10 months, with priority review shortening this to about 6 months. Overall, from submission to approval, it can range from 6 to 12 months.
   • Abbreviated New Drug Application (ANDA): Generally takes around 10 months. This timeframe can vary based on the completeness of the submission and FDA requests.

3. Biologics:

   • Biologics License Application (BLA): Typically takes about 10 months, with priority review reducing this to around 6 months. The total process may span 6 to 12 months, including preparation and communication.

4. Food Products:

   • Generally Recognized as Safe (GRAS) Notification: The review process can take several months to a year, depending on the complexity and data provided.

These timeframes are general estimates and can be influenced by factors such as submission quality, additional information requests, and the FDA’s workload.

Contact Us：

Whatsapp or Wechat：+86 15816864648；email address：hito.lin@grzan.cn